James M. Saunders

Statistics

Publications

Citations

328

H-Index

Active since

1965

Affiliations

Queen Elizabeth Hospital(Current)

Pfizer (United States)

James M. Saunders is an author at Queen Elizabeth Hospital specializing in antiviral structure-activity relationships, enzyme inhibition, and pharmacy.

Publications per year

1965–2001

Publications

Opsonophagocytic Killing Antibody to<i>Pseudomonas aeruginosa</i>Mucoid Exopolysaccharide in Older Noncolonized Patients with Cystic Fibrosis

Gerald B. Pier, James M. Saunders, Peter Ames et al. · New England Journal of Medicine · 1987 · 131 citations

Life Sciences, Immunology, Microbiology +17

Synthesis of 5,6-Dihydro-4-hydroxy-2- pyrones as HIV-1 Protease Inhibitors: The Profound Effect of Polarity on Antiviral Activity

Susan E. Hagen, J. V. N. Vara Prasad, F Boyer et al. · Journal of Medicinal Chemistry · 1997 · 62 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

4-Hydroxy-5,6-dihydropyrones as Inhibitors of HIV Protease: The Effect of Heterocyclic Substituents at C-6 on Antiviral Potency and Pharmacokinetic Parameters

Susan E. Hagen, John M. Domagala, Christopher Gajda et al. · Journal of Medicinal Chemistry · 2001 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

An Immunohistological Evaluation of Pseudomonas aeruginosa Pulmonary Infection in Two Patients with Cystic Fibrosis

David P. Speert, James E. Dimmick, Gerald B. Pier et al. · Pediatric Research · 1987 · 28 citations

Medicine, Infectious Diseases, Microbiology +11

Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitor

Jagdish Prasad, F Boyer, John M. Domagala et al. · Bioorganic & Medicinal Chemistry · 1999 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 7